Adams Street Partners LLC Fusion Pharmaceuticals Inc. Transaction History

Adams Street Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.83 - $9.41 $203,071 - $244,048	-25,935 Reduced 0.87%	2,947,809 $23.3 Million
Q2 2021 Aug 13, 2021	SELL	$7.97 - $10.66 $126,723 - $169,494	-15,900 Reduced 0.53%	2,973,744 $24 Million
Q1 2021 May 10, 2021	SELL	$9.75 - $13.09 $4.91 Million - $6.59 Million	-503,105 Reduced 14.4%	2,989,644 $32 Million
Q4 2020 Feb 11, 2021	SELL	$11.5 - $13.73 $111,274 - $132,851	-9,676 Reduced 0.28%	3,492,749 $41 Million
Q2 2020 Aug 13, 2020	BUY	$17.0 - $17.78 $59.5 Million - $62.3 Million	3,502,425 New	3,502,425 $55.1 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Adams Street Partners LLC with notifications on news.